Therefore, we hypothesized that serum sCD14 levels, shed from mCD14, might be highly correlated with hepatic CD14 expression levels in NASH patients, and could predict the severity of NASH, particularly liver inflammation. The gene discussed is CD14; the disease is metabolic dysfunction-associated steatohepatitis.